Geron Corporation GERN

Updated: 18 Jun 2026

NASDAQ | Biotech | Biotech / Blood cancer treatments

No signal published yet

We already track Geron and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Geron free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotech / Blood cancer treatments
We're already tracking Geron Corporation — here are the latest events we've registered

Recent News

  • On May 6, 2026, Geron reported Q1 2026 financial results, achieving $51.8 million in net product revenue for RYTELO, an 8% increase over the prior quarter. The company reiterated its full-year 2026 revenue guidance for RYTELO of $220 million to $240 million. In June 2026, the company presented at the Goldman Sachs 47th Annual Global Healthcare Conference.

What Firelda Watch includes for Geron Corporation

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Geron Corporation will be delivered in the same format.

Want to follow Geron Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Geron free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Geron Corporation GERN
Geron — follow and we'll monitor it
Follow Geron free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.